Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9398 |
High Similarity |
NPD9133 |
Approved |
0.9254 |
High Similarity |
NPD9628 |
Approved |
0.9197 |
High Similarity |
NPD1451 |
Approved |
0.8921 |
High Similarity |
NPD9183 |
Clinical (unspecified phase) |
0.8794 |
High Similarity |
NPD9627 |
Approved |
0.8767 |
High Similarity |
NPD2180 |
Approved |
0.8699 |
High Similarity |
NPD1731 |
Clinical (unspecified phase) |
0.8649 |
High Similarity |
NPD2604 |
Approved |
0.8444 |
Intermediate Similarity |
NPD300 |
Approved |
0.8421 |
Intermediate Similarity |
NPD3130 |
Discontinued |
0.8278 |
Intermediate Similarity |
NPD3697 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD875 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD3108 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD3105 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD5768 |
Phase 2 |
0.7319 |
Intermediate Similarity |
NPD9132 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD568 |
Approved |
0.7255 |
Intermediate Similarity |
NPD567 |
Approved |
0.7255 |
Intermediate Similarity |
NPD566 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8862 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8861 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8859 |
Approved |
0.6923 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.6803 |
Remote Similarity |
NPD1388 |
Phase 1 |
0.6803 |
Remote Similarity |
NPD1389 |
Clinical (unspecified phase) |
0.6803 |
Remote Similarity |
NPD1390 |
Phase 1 |
0.6702 |
Remote Similarity |
NPD8261 |
Discontinued |
0.6702 |
Remote Similarity |
NPD7465 |
Suspended |
0.6667 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6596 |
Remote Similarity |
NPD3497 |
Clinical (unspecified phase) |
0.6581 |
Remote Similarity |
NPD576 |
Discontinued |
0.6579 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.6486 |
Remote Similarity |
NPD8641 |
Approved |
0.6471 |
Remote Similarity |
NPD1249 |
Clinical (unspecified phase) |
0.6453 |
Remote Similarity |
NPD8292 |
Phase 2 |
0.6335 |
Remote Similarity |
NPD582 |
Approved |
0.631 |
Remote Similarity |
NPD8113 |
Phase 2 |
0.6271 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.625 |
Remote Similarity |
NPD8271 |
Discontinued |
0.6215 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.6188 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6139 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6135 |
Remote Similarity |
NPD2618 |
Phase 1 |
0.6135 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.6131 |
Remote Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.6114 |
Remote Similarity |
NPD8629 |
Discontinued |
0.61 |
Remote Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.6095 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.6087 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.6087 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.6062 |
Remote Similarity |
NPD1121 |
Approved |
0.6062 |
Remote Similarity |
NPD1120 |
Approved |
0.6054 |
Remote Similarity |
NPD7245 |
Approved |
0.6054 |
Remote Similarity |
NPD7246 |
Clinical (unspecified phase) |
0.6041 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.6036 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.6026 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.5989 |
Remote Similarity |
NPD2009 |
Clinical (unspecified phase) |
0.5979 |
Remote Similarity |
NPD459 |
Clinical (unspecified phase) |
0.5977 |
Remote Similarity |
NPD1335 |
Approved |
0.5965 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.5965 |
Remote Similarity |
NPD1030 |
Approved |
0.5965 |
Remote Similarity |
NPD1027 |
Approved |
0.596 |
Remote Similarity |
NPD7834 |
Approved |
0.5943 |
Remote Similarity |
NPD8119 |
Discontinued |
0.593 |
Remote Similarity |
NPD7981 |
Discontinued |
0.5922 |
Remote Similarity |
NPD245 |
Suspended |
0.5916 |
Remote Similarity |
NPD460 |
Discontinued |
0.5915 |
Remote Similarity |
NPD1118 |
Discontinued |
0.5899 |
Remote Similarity |
NPD1776 |
Approved |
0.5899 |
Remote Similarity |
NPD1777 |
Approved |
0.5896 |
Remote Similarity |
NPD1303 |
Phase 1 |
0.5894 |
Remote Similarity |
NPD4414 |
Discontinued |
0.5879 |
Remote Similarity |
NPD1430 |
Approved |
0.5879 |
Remote Similarity |
NPD1431 |
Approved |
0.5876 |
Remote Similarity |
NPD1122 |
Clinical (unspecified phase) |
0.5867 |
Remote Similarity |
NPD757 |
Phase 3 |
0.5867 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.5867 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.5862 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.5858 |
Remote Similarity |
NPD775 |
Approved |
0.5855 |
Remote Similarity |
NPD9360 |
Approved |
0.5829 |
Remote Similarity |
NPD2008 |
Discontinued |
0.5829 |
Remote Similarity |
NPD276 |
Clinical (unspecified phase) |
0.5821 |
Remote Similarity |
NPD1600 |
Suspended |
0.5821 |
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |
0.5806 |
Remote Similarity |
NPD3593 |
Approved |
0.5805 |
Remote Similarity |
NPD695 |
Discontinued |
0.5802 |
Remote Similarity |
NPD194 |
Clinical (unspecified phase) |
0.58 |
Remote Similarity |
NPD796 |
Phase 2 |
0.578 |
Remote Similarity |
NPD1369 |
Phase 2 |
0.578 |
Remote Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.5777 |
Remote Similarity |
NPD8258 |
Clinical (unspecified phase) |
0.5777 |
Remote Similarity |
NPD8257 |
Approved |
0.5777 |
Remote Similarity |
NPD8256 |
Approved |
0.5776 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.5775 |
Remote Similarity |
NPD2138 |
Approved |
0.5775 |
Remote Similarity |
NPD2137 |
Approved |
0.5771 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.5767 |
Remote Similarity |
NPD252 |
Clinical (unspecified phase) |
0.5759 |
Remote Similarity |
NPD515 |
Phase 1 |
0.5756 |
Remote Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.5756 |
Remote Similarity |
NPD7970 |
Approved |
0.575 |
Remote Similarity |
NPD9632 |
Phase 3 |
0.5744 |
Remote Similarity |
NPD2880 |
Discontinued |
0.5739 |
Remote Similarity |
NPD1290 |
Phase 2 |
0.5737 |
Remote Similarity |
NPD6418 |
Phase 1 |
0.5732 |
Remote Similarity |
NPD579 |
Clinical (unspecified phase) |
0.5728 |
Remote Similarity |
NPD3353 |
Approved |
0.5724 |
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.5724 |
Remote Similarity |
NPD341 |
Approved |
0.5724 |
Remote Similarity |
NPD340 |
Approved |
0.5723 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.5723 |
Remote Similarity |
NPD1354 |
Approved |
0.5723 |
Remote Similarity |
NPD1356 |
Approved |
0.5721 |
Remote Similarity |
NPD8105 |
Discontinued |
0.5721 |
Remote Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.5708 |
Remote Similarity |
NPD8075 |
Discontinued |
0.5707 |
Remote Similarity |
NPD7557 |
Clinical (unspecified phase) |
0.5705 |
Remote Similarity |
NPD8955 |
Approved |
0.5705 |
Remote Similarity |
NPD8954 |
Approved |
0.57 |
Remote Similarity |
NPD7980 |
Clinical (unspecified phase) |
0.5693 |
Remote Similarity |
NPD2443 |
Approved |
0.5693 |
Remote Similarity |
NPD2442 |
Approved |
0.5691 |
Remote Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.5686 |
Remote Similarity |
NPD1368 |
Approved |
0.5684 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.5682 |
Remote Similarity |
NPD1732 |
Phase 3 |
0.5682 |
Remote Similarity |
NPD2646 |
Discontinued |
0.5679 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.5674 |
Remote Similarity |
NPD1042 |
Clinical (unspecified phase) |
0.5661 |
Remote Similarity |
NPD2091 |
Phase 2 |
0.5661 |
Remote Similarity |
NPD2096 |
Phase 2 |
0.5659 |
Remote Similarity |
NPD2411 |
Approved |
0.5655 |
Remote Similarity |
NPD2179 |
Discontinued |
0.5654 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.5652 |
Remote Similarity |
NPD248 |
Discontinued |
0.5649 |
Remote Similarity |
NPD237 |
Clinical (unspecified phase) |
0.5644 |
Remote Similarity |
NPD3410 |
Approved |
0.5644 |
Remote Similarity |
NPD3411 |
Phase 2 |
0.5644 |
Remote Similarity |
NPD6328 |
Clinical (unspecified phase) |
0.5635 |
Remote Similarity |
NPD2134 |
Approved |
0.5635 |
Remote Similarity |
NPD2135 |
Approved |
0.5635 |
Remote Similarity |
NPD2136 |
Approved |
0.5629 |
Remote Similarity |
NPD549 |
Approved |
0.5629 |
Remote Similarity |
NPD193 |
Suspended |
0.5622 |
Remote Similarity |
NPD482 |
Approved |
0.5619 |
Remote Similarity |
NPD996 |
Phase 2 |
0.5619 |
Remote Similarity |
NPD6210 |
Phase 3 |
0.5619 |
Remote Similarity |
NPD2127 |
Suspended |
0.5619 |
Remote Similarity |
NPD994 |
Phase 2 |
0.5617 |
Remote Similarity |
NPD9650 |
Phase 3 |
0.5614 |
Remote Similarity |
NPD9724 |
Phase 1 |
0.5614 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.5613 |
Remote Similarity |
NPD307 |
Approved |
0.561 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.561 |
Remote Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.5608 |
Remote Similarity |
NPD2094 |
Phase 2 |
0.5608 |
Remote Similarity |
NPD2092 |
Phase 2 |
0.5608 |
Remote Similarity |
NPD2095 |
Phase 2 |
0.5607 |
Remote Similarity |
NPD6164 |
Phase 2 |
0.5607 |
Remote Similarity |
NPD6165 |
Phase 2 |
0.5606 |
Remote Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.5602
|
Remote Similarity |
NPD2793 |
Discontinued |